Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer

Urology

Volumn 68, Issue 1, 2006, Pages 121-125

  Joslyn, Sue A ^a   Konety, Badrinath R ^b  

^a UNIVERSITY OF NORTHERN IOWA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; TIME SERIES ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE;

EID: 33745822093     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.01.055     Document Type: Article

References (18)

1. Mathiesen O., Carl J., Bonderup O., et al. Axillary sampling and the risk of erroneous staging of breast cancer. an analysis of 960 consecutive patients. Acta Oncol 29 (1990) 721-725
2. Konety B.R., Joslyn S.A., and O'Donnell M.A. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer. analysis of data from the Surveillance, Epidemiology, and End Results Program database. J Urol 169 (2003) 946-950
3. DiMarco D.S., Zincke H., Sebo T.J., et al. The extent of lymphadenectomy for pTXN0 prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 173 (2005) 1121-1125
4. Bader P., Burkhard F.C., Markwalder R., et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514-518
5. Bader P., Burkhard F.C., Markwalder R., et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. is there a chance of cure?. J Urol 169 (2003) 849-854
6. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy. high incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
7. Miller D.C., Hafez K.S., Stewart A., et al. Prostate carcinoma presentation, diagnosis, and staging. an update from the National Cancer Data Base. Cancer 98 (2003) 1169-1178
8. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. a multi-institutional update. JAMA 277 (1997) 1445-1451
9. American Joint Committee on Cancer. AJCC Cancer Staging Handbook. 5th ed (1998), Lippincott-Raven, Philadelphia 205-206
10. Herr H.W., Bochner B.H., Dalbagni G., et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295-1298
11. Wawroschek F., Wagner T., Hamm M., et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 43 (2003) 132-137
12. Allaf M.E., Palapattu G.S., Trock B.J., et al. Anatomical extent of lymph node dissection. impact on men with clinically localized prostate cancer. J Urol 172 (2004) 1840-1844
13. Augustin H., Eggert T., Wenske S., et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. J Urol 171 (2004) 177-181
14. Weingartner K., Ramaswamy A., Bittinger A., et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer. results of an autopsy study and implications for the clinic. J Urol 156 (1996) 1969-1971
15. Clark T., Parekh D.J., Cookson M.S., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145-148
16. Daneshmand S., Quek M.L., Stein J.P., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy. long-term results. J Urol 172 (2004) 2252-2255
17. Cheng L., Zincke H., Blute M.L., et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91 (2001) 66-73
18. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597